FDA records linked by MedtechLedger show one 510(k) entry associated with Aspect Imaging, Ltd.: K261758 for the Embrace Vision Neonatal MRI System, product code LNH, advisory committee Radiology, received May 28, 2026 and decided September 16, 2026 as substantially equivalent (SESE). The applicant address on that record is in Shoham, Israel, which is a filing address rather than a verified headquarters. The same record lists a Summary as the statement or summary type and a Traditional clearance type. [1]

Documented filing and device identity

K261758 identifies the device as the Embrace Vision Neonatal MRI System and classifies it under the openFDA device name System, Nuclear Magnetic Resonance Imaging, device class 2, regulation number 892.1000, medical specialty Radiology. The record carries product code LNH and a decision description of Substantially Equivalent. The applicant is listed as Aspect Imaging, Ltd., with contact Yaron Eshel and country code IL. [1]

A separate FDA substantial equivalence determination, K254277 dated March 13, 2026, concerns the Embrace Neonatal MRI System under the same regulation, 21 CFR 892.1000, Class II, with product codes LNH and MOS. That document states an intended use of producing axial, sagittal, coronal and oblique images of the neonatal head with circumference up to 38 cm and weight between 1 kg and 4.5 kg, and names K170978 as the predicate device. [6]

Published product descriptions

Aspect Imaging's clinical imaging page describes the company as developing patient-focused diagnostic imaging without the complexity, added time and costs often associated with conventional MRI systems, and presents the Embrace Neonatal MRI System within that framing. The page also references room requirements and a safety zone in its own wording. [4]

The Embrace product site states that the Embrace Neonatal MRI System is the first FDA-cleared imaging system designed specifically for use inside the NICU, and describes scanning critically ill or premature NICU patients within minutes of the order while addressing risks associated with off-unit transport. The same site describes Aspect Imaging as a global leader in compact MR imaging systems for preclinical and medical applications. [5]

A technology page published for Embrace describes high-resolution axial, sagittal, coronal and oblique MR images of the internal structure and function of the infant brain and mentions DICOM images. Aspect Imaging's corporate site describes permanent-magnet design and self-shielded systems intended to be placed without the infrastructure requirements associated with superconducting MRI, and lists M-Series compact preclinical MRI among its offerings. [7][8]

How to read the collection

The linked collection totals one 510(k) record, and that single record's decision count is SESE; the smaller record sample likewise contains one SESE entry, K261758. These counts describe the filings assembled as of the snapshot date and are not measures of total company sales, total portfolio or safety performance. No recall records appear in the linked sample. [1]

The FDA 510(k) database pages retrieved for K261758 present the standard premarket notification interface and agency navigation text rather than additional device-specific content, so device scope here rests on the structured record and the determination document. [2][3]